X0306 4/A 2021-11-15 2021-11-17 0 0001835632 Marvell Technology, Inc. MRVL 0001680691 Hussain Muhammad Raghib 5488 MARVELL LANE SANTA CLARA CA 95054 0 1 0 0 President, Products & Tech Common Stock 2021-11-15 4 M 0 72976 12.12 A 640662 D Common Stock 2021-11-15 4 M 0 25991 15.59 A 666653 D Common Stock 2021-11-15 4 M 0 25990 15.59 A 692643 D Common Stock 2021-11-15 4 S 0 52796 72.34 D 639847 D Common Stock 2021-11-15 4 S 0 44195 72.80 D 595652 D Common Stock 2021-11-15 4 S 0 3009 73.63 D 592643 D Common Stock 2021-11-15 4 S 0 69083 72.35 D 523560 D Common Stock 2021-11-15 4 S 0 52287 72.82 D 471273 D Common Stock 2021-11-15 4 S 0 3587 73.63 D 467686 D Common Stock 2021-11-16 4 S 0 100000 72.33 D 367686 D Common Stock 88081 I By Family Trusts Non-Qualified Stock Option 12.12 2021-11-15 4 M 0 72976 0.00 D Common Stock 72976 0 D Non-Qualified Stock Option 15.59 2021-11-15 4 M 0 25991 0.00 D Common Stock 25991 0 D Non-Qualified Stock Option 15.59 2021-11-15 4 M 0 25990 0.00 D Common Stock 25990 0 D Starting share total was incorrectly reported on previous 11.17.2021 filing due to a clerical error. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.56 to $72.56, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.57 to $73.58, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.68, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.58 to $72.58, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.59 to $73.59, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.65, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.01 to $72.79, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family. The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person. The stock options completely vested on 11/01/2018. The stock options completely vested on 02/16/2019. Raghib Hussain by Blair Walters as Attorney-In-Fact Raghib Hussain by Blair Walters as Attorney-in-Fact 2021-11-18